Azvudine, developed by Chinese drugmaker Genuine Biotech, outperformed Paxlovid in a study of 3600 hospitalised patients: 
- ⬆️ survival rate
- ⬇️ reported side effects

Of note: #azvudine was particularly beneficial for patients initiating treatment &gt;5 days after diagnosis.
#azvudine
#azvudine